212 related articles for article (PubMed ID: 7664348)
21. The effects of PEG grafting level and injection dose on gold nanorod biodistribution in the tumor-bearing mice.
Akiyama Y; Mori T; Katayama Y; Niidome T
J Control Release; 2009 Oct; 139(1):81-4. PubMed ID: 19538994
[TBL] [Abstract][Full Text] [Related]
22. [A review on the influences of size and surface charge of liposome on its targeted drug delivery in vivo].
Yang YF; Xie XY; Yang Y; Zhang H; Mei XG
Yao Xue Xue Bao; 2013 Nov; 48(11):1644-50. PubMed ID: 24475700
[TBL] [Abstract][Full Text] [Related]
23. In vivo fate of folate-targeted polyethylene-glycol liposomes in tumor-bearing mice.
Gabizon A; Horowitz AT; Goren D; Tzemach D; Shmeeda H; Zalipsky S
Clin Cancer Res; 2003 Dec; 9(17):6551-9. PubMed ID: 14695160
[TBL] [Abstract][Full Text] [Related]
24. Therapeutic effect of reticuloendothelial system (RES)-avoiding liposomes containing a phospholipid analogue of 5-fluorouracil, dipalmitoylphosphatidylfluorouridine, in Meth A sarcoma-bearing mice.
Doi K; Oku N; Toyota T; Shuto S; Sakai A; Itoh H; Okada S
Biol Pharm Bull; 1994 Oct; 17(10):1414-6. PubMed ID: 7874068
[TBL] [Abstract][Full Text] [Related]
25. Role of liposome size and RES blockade in controlling biodistribution and tumor uptake of GM1-containing liposomes.
Liu D; Mori A; Huang L
Biochim Biophys Acta; 1992 Feb; 1104(1):95-101. PubMed ID: 1550858
[TBL] [Abstract][Full Text] [Related]
26. Anti-neovascular therapy by use of tumor neovasculature-targeted long-circulating liposome.
Maeda N; Takeuchi Y; Takada M; Sadzuka Y; Namba Y; Oku N
J Control Release; 2004 Nov; 100(1):41-52. PubMed ID: 15491809
[TBL] [Abstract][Full Text] [Related]
27. Long-circulating sterically stabilized liposomes in the treatment of infections.
Bakker-Woudenberg IA; Schiffelers RM; Storm G; Becker MJ; Guo L
Methods Enzymol; 2005; 391():228-60. PubMed ID: 15721385
[TBL] [Abstract][Full Text] [Related]
28. Oxaliplatin encapsulated in PEG-coated cationic liposomes induces significant tumor growth suppression via a dual-targeting approach in a murine solid tumor model.
Abu Lila AS; Kizuki S; Doi Y; Suzuki T; Ishida T; Kiwada H
J Control Release; 2009 Jul; 137(1):8-14. PubMed ID: 19285528
[TBL] [Abstract][Full Text] [Related]
29. Long-circulating gadolinium-encapsulated liposomes for potential application in tumor neutron capture therapy.
Le UM; Cui Z
Int J Pharm; 2006 Apr; 312(1-2):105-12. PubMed ID: 16457973
[TBL] [Abstract][Full Text] [Related]
30. Effective anti-tumor activity of oxaliplatin encapsulated in transferrin-PEG-liposome.
Suzuki R; Takizawa T; Kuwata Y; Mutoh M; Ishiguro N; Utoguchi N; Shinohara A; Eriguchi M; Yanagie H; Maruyama K
Int J Pharm; 2008 Jan; 346(1-2):143-50. PubMed ID: 17640835
[TBL] [Abstract][Full Text] [Related]
31. Enhanced loading efficiency and retention of 225Ac in rigid liposomes for potential targeted therapy of micrometastases.
Chang MY; Seideman J; Sofou S
Bioconjug Chem; 2008 Jun; 19(6):1274-82. PubMed ID: 18505278
[TBL] [Abstract][Full Text] [Related]
32. Entrapment of small molecules and nucleic acid-based drugs in liposomes.
Fenske DB; Cullis PR
Methods Enzymol; 2005; 391():7-40. PubMed ID: 15721372
[TBL] [Abstract][Full Text] [Related]
33. Tumor imaging with technetium-99m-DTPA encapsulated in RES-avoiding liposomes.
Oku N; Namba Y; Takeda A; Okada S
Nucl Med Biol; 1993 May; 20(4):407-12. PubMed ID: 8504283
[TBL] [Abstract][Full Text] [Related]
34. Influence of the physicochemical properties of liposomes on the accelerated blood clearance phenomenon in rats.
Wang XY; Ishida T; Ichihara M; Kiwada H
J Control Release; 2005 May; 104(1):91-102. PubMed ID: 15866337
[TBL] [Abstract][Full Text] [Related]
35. Complete remission of experimental arthritis by joint targeting of glucocorticoids with long-circulating liposomes.
Metselaar JM; Wauben MH; Wagenaar-Hilbers JP; Boerman OC; Storm G
Arthritis Rheum; 2003 Jul; 48(7):2059-66. PubMed ID: 12847701
[TBL] [Abstract][Full Text] [Related]
36. Pegylated liposomes have potential as vehicles for intratumoral and subcutaneous drug delivery.
Harrington KJ; Rowlinson-Busza G; Syrigos KN; Uster PS; Vile RG; Stewart JS
Clin Cancer Res; 2000 Jun; 6(6):2528-37. PubMed ID: 10873109
[TBL] [Abstract][Full Text] [Related]
37. The liposomal formulation of doxorubicin.
Abraham SA; Waterhouse DN; Mayer LD; Cullis PR; Madden TD; Bally MB
Methods Enzymol; 2005; 391():71-97. PubMed ID: 15721375
[TBL] [Abstract][Full Text] [Related]
38. Liposomes for scintigraphic imaging: optimization of in vivo behavior.
Boerman OC; Oyen WJ; Corstens FH; Storm G
Q J Nucl Med; 1998 Dec; 42(4):271-9. PubMed ID: 9973842
[TBL] [Abstract][Full Text] [Related]
39. Pulmonary delivery of insulin by liposomal carriers.
Huang YY; Wang CH
J Control Release; 2006 Jun; 113(1):9-14. PubMed ID: 16730838
[TBL] [Abstract][Full Text] [Related]
40. [The distribution of azidothymidine palmitate galactosylated liposomes in mice].
Wu HB; Deng YH; Wang SN; Zhou XY; Wang N; Shi L
Yao Xue Xue Bao; 2007 May; 42(5):538-44. PubMed ID: 17703780
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
